Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Global Payments
GPN
$24.7B
| $27.8M | 0.05% |
485,046
-1,232,650
| -72% | -$68.4M |
|
427
W.R. Berkley
WRB
$25.5B
| $27.8M | 0.05% |
1,726,464
+728,787
| +73% | +$11.9M |
|
|
SWFT
428
DELISTED
Swift Transportation Company
SWFT
| $27.7M | 0.05% |
1,843,817
+1,200,256
| +187% | +$25.3M |
|
429
Kraft Heinz
KHC
$30.3B
| $27.7M | 0.05% |
+392,140
| New | +$29.6M |
|
430
Capital One
COF
$134B
| $27.5M | 0.05% |
+379,553
| New | +$30.5M |
|
431
PENN Entertainment
PENN
$2.5B
| $27.5M | 0.05% |
1,640,136
+557,712
| +52% | +$10.2M |
|
|
HOUS
432
DELISTED
Anywhere Real Estate
HOUS
| $27.4M | 0.05% |
+728,883
| New | +$31.8M |
|
|
CLVS
433
DELISTED
Clovis Oncology, Inc.
CLVS
| $27.4M | 0.05% |
+297,805
| New | +$25.8M |
|
|
AL
434
DELISTED
Air Lease Corp
AL
| $27.3M | 0.05% |
884,407
-103,196
| -10% | -$3.44M |
|
|
MDVN
435
DELISTED
MEDIVATION, INC.
MDVN
| $27.3M | 0.05% |
641,400
+85,140
| +15% | +$4.22M |
|
436
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $27.2M | 0.05% |
142,100
-3,945,100
| -97% | -$800M |
|
437
Illinois Tool Works
ITW
$80.4B
| $27.2M | 0.05% |
330,296
+42,550
| +15% | +$3.72M |
|
438
PUT
Transocean
RIG
$6.61B
| $27.2M | 0.05% |
+2,103,700
| New | +$29.2M |
|
|
ESL
439
DELISTED
Esterline Technologies
ESL
| $27.1M | 0.05% |
377,062
+291,835
| +342% | +$24.8M |
|
440
Viatris
VTRS
$18.7B
| $27M | 0.05% |
671,445
+246,263
| +58% | +$13.7M |
|
441
Crown Holdings
CCK
$13B
| $27M | 0.05% |
590,096
+296,089
| +101% | +$15M |
|
442
Oil States International
OIS
$522M
| $26.9M | 0.05% |
1,029,125
+1,019,067
| +10,132% | +$30.2M |
|
|
VR
443
DELISTED
Validus Hold Ltd
VR
| $26.9M | 0.05% |
595,930
+424,555
| +248% | +$19.2M |
|
|
RHT
444
DELISTED
Red Hat Inc
RHT
| $26.7M | 0.05% |
371,625
-310,275
| -46% | -$23.4M |
|
|
PXD
445
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $26.6M | 0.05% |
218,700
+147,700
| +208% | +$18.4M |
|
446
Aptiv
APTV
$10B
| $26.4M | 0.05% |
347,239
+191,450
| +123% | +$14.7M |
|
447
Robert Half
RHI
$4.58B
| $26.4M | 0.05% |
515,895
+407,430
| +376% | +$21.9M |
|
|
ROIC
448
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $26.3M | 0.05% |
1,591,893
-259,166
| -14% | -$4.28M |
|
449
Acadia Pharmaceuticals
ACAD
$5.08B
| $26.3M | 0.05% |
795,025
-255,004
| -24% | -$10.6M |
|
450
Rio Tinto
RIO
$171B
| $26.2M | 0.05% |
776,135
+501,882
| +183% | +$18.8M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.